Published in J Clin Invest on October 01, 1985
Vitamin D and Osteoporosis Prevention in Elderly African American Women (NIHD) | NCT01153568
High-dose Vitamin D Supplements in Older Adults | NCT03613116
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer (2008) 4.34
Vitamin D insufficiency in a population of healthy western Canadians. CMAJ (2002) 2.73
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys (2007) 2.39
Vitamin D in health and disease. Clin J Am Soc Nephrol (2008) 2.24
On the epidemiology of influenza. Virol J (2008) 2.17
Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2008) 2.08
Not enough vitamin D: health consequences for Canadians. Can Fam Physician (2007) 2.03
Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73
Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr (2010) 1.67
Determining vitamin D status: a comparison between commercially available assays. PLoS One (2010) 1.49
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab (2016) 1.43
Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr (2009) 1.42
Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol (2013) 1.41
Vitamin D in health and disease: current perspectives. Nutr J (2010) 1.31
Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr (2008) 1.29
Optimal management of sarcopenia. Clin Interv Aging (2010) 1.29
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One (2009) 1.25
Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int (2006) 1.24
Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int J Cancer (2012) 1.23
Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol (2011) 1.23
Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev (2006) 1.20
The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients (2010) 1.18
Sunlight and other determinants of circulating 25-hydroxyvitamin D levels in black and white participants in a nationwide U.S. study. Am J Epidemiol (2013) 1.18
Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMC Public Health (2008) 1.18
Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am (2010) 1.18
Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health (2011) 1.14
Vitamin D - a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations. Food Nutr Res (2013) 1.11
Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites. Cancer Causes Control (2009) 1.10
Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health. Eur J Nutr (2012) 1.08
How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int (2006) 1.08
Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J Biol Chem (2011) 1.07
Influence of season, ethnicity, and chronicity on vitamin D deficiency in traumatic spinal cord injury. J Spinal Cord Med (2010) 1.06
In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance. Dermatoendocrinol (2009) 1.06
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis (2015) 1.06
Vitamin D: a critical and essential micronutrient for human health. Front Physiol (2014) 1.05
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05
The effects of air pollution on vitamin D status in healthy women: a cross sectional study. BMC Public Health (2010) 1.05
Inflammation and vitamin D: the infection connection. Inflamm Res (2014) 1.05
Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs (2011) 1.03
The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study. Rheumatol Int (2011) 1.03
Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians. Diabetes Care (2011) 1.03
Vitamin d status in central europe. Int J Endocrinol (2014) 1.02
Acute erythemal ultraviolet radiation causes systemic immunosuppression in the absence of increased 25-hydroxyvitamin D3 levels in male mice. PLoS One (2012) 1.01
Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2. Am J Clin Nutr (2009) 1.00
Vitamin D Deficiency and Its Health Consequences in Africa. Clin Rev Bone Miner Metab (2009) 1.00
Vitamin D status and sun exposure in southeast Asia. Dermatoendocrinol (2013) 0.99
Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporos Int (2011) 0.98
Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer (2005) 0.97
Low dietary vitamin D predicts 34-year incident stroke: the Honolulu Heart Program. Stroke (2012) 0.96
Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis. Int J Cancer (2009) 0.96
Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D). PLoS One (2014) 0.95
Vitamin d status in Korea. Endocrinol Metab (Seoul) (2013) 0.95
High latitude and marine diet: vitamin D status in elderly Faroese. Br J Nutr (2010) 0.94
Brazilian consensus on photoprotection. An Bras Dermatol (2015) 0.94
Medicine in the elderly. Postgrad Med J (1991) 0.93
Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol (2009) 0.93
Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr (2012) 0.93
DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes. BMC Evol Biol (2013) 0.93
Seasonality of hip fractures and estimates of season-attributable effects: a multivariate ARIMA analysis of population-based data. Osteoporos Int (2006) 0.93
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int (2011) 0.91
Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol (2009) 0.91
Effects of sunlight and diet on vitamin D status of pulmonary tuberculosis patients in Tbilisi, Georgia. Nutrition (2012) 0.90
Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents. BMC Geriatr (2012) 0.90
Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropics. Clin Interv Aging (2013) 0.89
Associations between 25-hydroxyvitamin D and weight gain in elderly women. J Womens Health (Larchmt) (2012) 0.89
Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation. Nutrients (2015) 0.89
Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88
Vitamin D and neurocognitive function. Clin Interv Aging (2014) 0.87
An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production. Dermatoendocrinol (2010) 0.87
Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease. Nutrients (2013) 0.87
Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury. J Spinal Cord Med (2009) 0.86
Solar UV doses of young Americans and vitamin D3 production. Environ Health Perspect (2011) 0.86
VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp Clin Trials (2015) 0.85
Vitamin D every day to keep the infection away? Nutrients (2015) 0.85
Serum 25-hydroxyvitamin d deficiency in ischemic stroke and subtypes in Indian patients. J Stroke (2014) 0.85
Vitamin D and cardiovascular disease: an appraisal of the evidence. Clin Chem (2013) 0.84
Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health (2007) 0.84
Seasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude. Med Sci Monit (2014) 0.84
Vitamin D and aging. Endocrinol Metab Clin North Am (2013) 0.83
Quality and adequacy of dietary intake in a southern urban heart failure population. J Cardiovasc Nurs (2013) 0.82
Vitamin D status of older adults of diverse ancestry living in the Greater Toronto Area. BMC Geriatr (2013) 0.82
Serum 25-hydroxyvitamin d and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. J Gerontol A Biol Sci Med Sci (2014) 0.82
Vitamin D and bone health: potential mechanisms. Nutrients (2010) 0.81
Resurgence of vitamin D: Old wine in new bottle. J Clin Orthop Trauma (2015) 0.81
Vitamin D status in Malaysian men and its associated factors. Nutrients (2014) 0.81
Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health? Eur J Epidemiol (2014) 0.81
Additive association of vitamin D insufficiency and sarcopenia with low femoral bone mineral density in noninstitutionalized elderly population: the Korea National Health and Nutrition Examination Surveys 2009-2010. Osteoporos Int (2013) 0.81
New perspectives on vitamin D sources in Germany based on a novel mathematical bottom-up model of 25(OH)D serum concentrations. Eur J Nutr (2012) 0.81
Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study. Osteoporos Int (2015) 0.80
Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners. Osteoporos Int (2016) 0.80
The Epidemiological Scale of Alzheimer's Disease. J Clin Med Res (2015) 0.80
High prevalence of vitamin D deficiency in adults aged 50 years and older in Gwangju, Korea: the Dong-gu Study. J Korean Med Sci (2013) 0.80
The effect of outfitting style on bone mineral density. Rheumatol Int (2007) 0.80
Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation. Eur J Clin Nutr (2013) 0.80
Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr Disord (2010) 0.80
Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. J Nutr (2014) 0.80
Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int (2014) 0.80
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Osteomalacia--a common disease in elderly women. J Bone Joint Surg Br (1967) 2.24
Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet (1974) 2.12
Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol (1982) 1.92
Nutrition and metabolic bone disease in old age. Lancet (1966) 1.85
Osteomalacia in elderly patients with fracture of the femoral neck. A clinico-pathological study. J Bone Joint Surg Br (1973) 1.36
Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr (1982) 1.35
Seasonal variation in serum-25-hydroxyvitamin-D in the elderly in Britain. Lancet (1977) 1.32
Structural changes in aging human skin. J Invest Dermatol (1979) 1.24
Response of plasma-25-hydroxyvitamin D to ultraviolet irradiation in long-stay geriatric patients. Lancet (1978) 1.20
Inadequate status and impaired metabolism of vitamin D in the elderly. Isr J Med Sci (1981) 1.19
Osteoporosis and osteomalacia. Clin Endocrinol Metab (1980) 1.15
Occult osteomalacia in American (U.S.A.) patients with fracture of the hip. Am J Surg Pathol (1978) 1.14
The calcium and vitamin D status in an elderly female population and their response to administered supplemental vitamin D3. J Gerontol (1977) 1.02
Assessment of plasma 25-hydroxyvitamin D response to ultraviolet irradiation over a controlled area in young and elderly subjects. Clin Sci (Lond) (1980) 1.01
Vitamin D status of the elderly in relation to age and exposure to sunlight. Hum Nutr Clin Nutr (1984) 0.94
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab (1988) 7.09
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet (1982) 6.40
Epidemic influenza and vitamin D. Epidemiol Infect (2006) 5.32
Redefining vitamin D insufficiency. Lancet (1998) 5.26
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Ultraviolet B and blood pressure. Lancet (1998) 2.83
Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A (1972) 2.77
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science (1972) 2.50
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 2.50
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr (1994) 2.22
Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science (1981) 2.20
A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite. J Lipid Res (1971) 2.12
Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07
Hypervitaminosis D associated with drinking milk. N Engl J Med (1992) 1.90
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science (1982) 1.80
Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci U S A (1971) 1.78
Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem (1990) 1.76
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69
21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. Biochemistry (1970) 1.65
An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr (1990) 1.65
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
Race/ethnic differences in bone mineral density in men. Osteoporos Int (2007) 1.63
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry (1972) 1.62
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet (2001) 1.61
1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52
Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med (2001) 1.51
Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1973) 1.50
Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology (1974) 1.48
Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) Cancer Causes Control (1998) 1.46
Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial. Br J Dermatol (2013) 1.46
25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. Biochemistry (1970) 1.40
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology (1981) 1.40
High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int (2006) 1.39
Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol (1986) 1.35
Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab (1997) 1.34
Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med (1981) 1.33
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1975) 1.33
The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol (1981) 1.32
Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr (1985) 1.30
Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab (1985) 1.30
Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest (1995) 1.30
Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun (1977) 1.30
Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol (1988) 1.30
Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med (1982) 1.29
Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc (1987) 1.29
Vitamin D and cancer. Anticancer Res (2006) 1.28
1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance. Pediatr Res (1975) 1.28
1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats. Science (1972) 1.26
Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr (1986) 1.25
Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy. Can Med Assoc J (1975) 1.24
An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol (2007) 1.24
Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab (1989) 1.21
The physiologic significance of plasma transport of vitamin D and metabolites. Am J Med (1974) 1.20
Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab (1992) 1.20
1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem (1973) 1.17
Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal calcium transport. Proc Natl Acad Sci U S A (1971) 1.15
A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem (1990) 1.14
The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr (1988) 1.13
Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab (1998) 1.13
The photobiogenesis and metabolism of vitamin D. Fed Proc (1978) 1.10
A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science (1983) 1.10
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . Science (1973) 1.10
Relationship of 25-hydroxyvitamin D3 side chain structure to biological activity. J Biol Chem (1975) 1.08
Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol (2007) 1.08
A method for the determination of the circulating concentration of vitamin D. J Nutr Biochem (1990) 1.08
Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis (2011) 1.07
The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res (1997) 1.07
Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem (1993) 1.07
Premature graying of hair is a risk marker for osteopenia. J Clin Endocrinol Metab (1994) 1.06
Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1983) 1.05
Silica Sep-Pak preparative chromatography for vitamin D and its metabolites. J Chromatogr (1981) 1.05
Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism. Metabolism (1975) 1.04
Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med (1995) 1.03
Synthesis of 1alpha-hydroxy [6-3H]vitamin D3 and its metabolism to 1alpha, 25-dihydroxy [6-3H]vitamin D3 in the rat. J Biol Chem (1976) 1.03
Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol (1996) 1.02
Characterization of the translocation process of vitamin D3 from the skin into the circulation. Endocrinology (1994) 1.01
Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3. Science (1975) 1.00
Expression of the circadian clock genes clock and period1 in human skin. J Invest Dermatol (2000) 0.98
The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa. S Afr Med J (1996) 0.98
An update on the vitamin D content of fortified milk from the United States and Canada. N Engl J Med (1993) 0.98
X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferol. Lancet (1973) 0.98
Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. J Steroid Biochem Mol Biol (2005) 0.98
Gas chromatography-mass spectrometry of conjugated dienes by derivatization with 4-methyl-1,2,4-triazoline-3,5-dione. J Chromatogr (1990) 0.98
The role of vitamin D metabolites in bone resorption. Calcif Tissue Res (1973) 0.97
A liposomal model that mimics the cutaneous production of vitamin D3. Studies of the mechanism of the membrane-enhanced thermal isomerization of previtamin D3 to vitamin D3. J Biol Chem (1999) 0.97
Measurement of circulating vitamin D in man. Clin Chim Acta (1982) 0.96
Demonstration of a receptor-like binding protein for 1,25-(OH)2-D3 in cultured intestinal epithelial cells from the adult rat. FEBS Lett (1982) 0.95
Is psoriasis a T-cell disease? Exp Dermatol (2000) 0.95
Transient osteoporosis of hip in pregnancy. J Clin Densitom (2000) 0.95
Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology (2001) 0.94
A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol (1988) 0.93
Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid (2001) 0.93
Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation. Acta Derm Venereol (1997) 0.93
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res (2000) 0.92
A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist. J Invest Dermatol (2001) 0.91